Roche Says Phase III Celestimo Study Hits Primary Endpoint
Roche said its Phase III Celestimo study met the primary endpoint in follicular lymphoma.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.